Byline: Anna Williams
-
Scientists Identify Mutations in Venous Valve Disease
Mutations in the genes FOXC2 and GJC2 are associated with defects in venous valves, according to a new study published in the Journal of Experimental Medicine.
-
Assessing the Accuracy of Cardiovascular Data in Electronic Health Records
Northwestern Medicine investigators identified key areas of agreement and disagreement between cardiovascular data collected from electronic health records and data gathered in a traditional cohort study.
-
Scientists Discover Neural Link Between Generosity and Happiness
A new study published in Nature Communications finds that practicing generosity activates an area of the brain associated with reward and happiness.
-
Precision Medicine for “All of Us”
Northwestern will play a key role in “All of Us,” a groundbreaking national research effort to gather data from one million or more people in order to advance precision medicine.
-
New Insights Into Protein’s Role in Inflammatory Response
A protein called POP2 inhibits a key inflammatory pathway, calming the body’s inflammatory response before it can become destructive, Northwestern Medicine scientists have found.
-
Novel Screening Method Reveals Glioblastoma Drug Target
Scientists used a new approach to identify a promising therapeutic target for glioblastoma, which was previously overlooked in traditional approaches.
-
Investigating Relevance of Internal Medicine Recertification Exam
Almost 70 percent of questions on the American Board of Internal Medicine’s Maintenance of Certification exam concurred with the frequency of conditions seen in general internal medicine practice, according to a JAMA study.
-
Investigating the Survival Benefit of Aggressive Procedure for Melanoma
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
-
Investigating the Financial Burden of Cancer Drugs on Medicare Patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare’s prescription drug benefit program, Part D, according to a new study.
-
PhD Student Explores Enzyme’s Role in Aggressive Brain Tumor
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
